| |
Complete PCI group |
Culprit only PCI group |
χ2 value or t value |
P Value |
| (n=24) |
(n=50) |
| Age (years) |
61.62±10.17 |
62.82±10.38 |
1.12* |
0.765 |
| Gender (Male) (%) |
19 (79.1) |
41 (82) |
0.09 |
0.771 |
| History of hypertension (%) |
20(83.3) |
42(84) |
0.01 |
0.942 |
| History of diabetes (%) |
14(58.3) |
30(60) |
0.02 |
0.891 |
| Smoking history (%) |
17(70.8) |
36(72) |
0.01 |
0.917 |
| Family history of coronary heart disease (%) |
4(16.7) |
8(16) |
0.01 |
0.942 |
| Glucose mmol/l |
7.15±1.23 |
7.23±1.35 |
-0.74* |
0.736 |
| Cholesterol mmol/l |
4.58±1.26 |
4.60±1.35 |
2.23* |
0.157 |
| High-density lipoprotein mmol/l |
0.92±0.33 |
0.94±0.22 |
-0.42* |
0.149 |
| Low-density lipoprotein mmol/l |
3.20±1.07 |
3.19±1.04 |
0.77* |
0.333 |
| Triglyceride mmol/l |
1.82±1.04 |
1.81±1.06 |
1.69* |
0.282 |
| Creatinineumol/l |
73.13±43.15 |
72.12±43.23 |
3.57* |
0.978 |
| CKMB ug/l |
177.68±78.28 |
178.56±78.34 |
-2.26* |
0.958 |
| cTnIng/ml |
17.28±9.36 |
17.15±9.22 |
1.56* |
0.698 |
| Left ventricular ejection fraction (%) |
57.39±4.65 |
57.23±4.59 |
-2.85* |
0.697 |
| Killip class III/IV at admission (%) |
3(12.5) |
6(12) |
0 |
0.951 |
| Statins (%) |
22 (91.7) |
45 (90) |
0.05 |
0.819 |
| ACEI (or ARB) (%) |
19 (79.1) |
41(82) |
0.09 |
0.771 |
| BB (%) |
19 (79.1) |
40 (80) |
0.01 |
0.933 |
| ASA (%) |
21 (87.5) |
46 (92) |
0.38 |
0.536 |
| Clopidogrel (%) |
22 (91.7) |
48 (96) |
0.6 |
0.440 |
| Note: *means t value, all others are χ2 value; ACEI (ARB): angiotensin-converting enzyme inhibitors (angiotensin ӀI receptor antagonist); BB: Beta Blockers; ASA: Aspirin; CKMB: creatine kinase MB; cTnI: cardiac troponin I |
